Visipill is a cloud-connected home appliance that loads, schedules, and securely dispenses medication by person, and lets every patient actually see their dose. Built to take on the $300-billion adherence problem.
Today's system does little to help patients with chronic illness stay educated, accountable, and adherent. People forget doses, take the wrong amount, or stop entirely, and the cost lands on patients, caregivers, insurers, and the whole healthcare system.
Visipill belongs on the kitchen counter, not in a drawer. A pharmacist schedules the plan, the household loads the medicine, and Visipill takes it from there, dispensing the right dose to the right person and tracking every one.
Bulk-load prescriptions into refillable canisters. Visipill detects and verifies what's inside.
Doses are scheduled by a pharmacist per the doctor's instructions, and synced to the cloud.
A fingerprint unlocks each person's profile. The dose drops into an illuminated cup you can see.
Every dose is tracked, caregivers get alerts on misses, and refills reorder automatically.
One fingerprint loads the right person's plan. In a household, no one ever gets the wrong medicine by mistake.
A transparent, LED-lit cup shows exactly what was dispensed, the reassurance the name "Visipill" is built on.
A patented method to pick, place, and return pills to the correct vial, with near-zero medication errors, far above the field.
Real-time adherence tracking with instant alerts to family or caretakers the moment a dose is missed.
Visipill tracks supply and reorders refills automatically, keeping the pharmacy in the loop end-to-end.
A built-in screen and camera connect patients to care without leaving home, a channel most dispensers simply don't have.
Figures from Visipill internal testing and a 2026 competitor review. Beta accuracy reflects internal trials.
Visipill is built to start where the need is most acute and the buyers are concentrated, then expand into the home and beyond.
Geriatric care is a $1.01T market. We start in ALF and nursing facilities to build brand, revenue, and clinical proof.
A $500B opportunity: the smart appliance for every home managing chronic medication.
A $44.2B market where verified, time-stamped adherence data is genuinely valuable to sponsors.
Every device sold opens a subscription relationship, connecting the patient, the pharmacy, and the caregiver, and compounding over the install base.
The overview covers the company, the $10–12M Series A, and the team, and how to reach us.